Abstract
Objectives:
Evaluation of a non-synonymous mutation associated with dihydropyrimidine dehydrogenase (DPD) deficiency.
Design and methods:
DPD enzyme analysis, mutation analysis and molecular dynamics simulations based on the 3D-model of DPD.
Results:
The substitution Lys63Glu is likely to affect the FAD binding pocket within the DPD protein and contributes to a near-complete DPD deficiency in a patient with developmental retardation.
Conclusions:
Like other DPD variants attenuating FAD binding, Lys63Glu should be included in screening for DPD deficiency.
Copyright © 2011. Published by Elsevier Inc.
MeSH terms
-
Amino Acid Sequence
-
Child
-
Creatinine / urine
-
Dihydropyrimidine Dehydrogenase Deficiency / urine*
-
Dihydrouracil Dehydrogenase (NADP) / chemistry
-
Dihydrouracil Dehydrogenase (NADP) / genetics*
-
Dihydrouracil Dehydrogenase (NADP) / metabolism
-
Flavin-Adenine Dinucleotide / metabolism*
-
Genotype
-
Humans
-
Male
-
Molecular Sequence Data
-
Mutation, Missense / genetics*
-
Protein Binding / genetics
-
Protein Binding / physiology
-
Sequence Homology, Amino Acid
-
Thymine / urine
-
Uracil / analogs & derivatives
-
Uracil / urine
Substances
-
dihydrouracil
-
Flavin-Adenine Dinucleotide
-
Uracil
-
Creatinine
-
Dihydrouracil Dehydrogenase (NADP)
-
Thymine